Clinical Trials Logo

Skin Diseases clinical trials

View clinical trials related to Skin Diseases.

Filter by:

NCT ID: NCT04345094 Completed - Photoaging Clinical Trials

Evaluation of Hexyresorcinol vs Hydroquinone for Photoaging

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Photoaging is a common concern within the cosmeceutical industry with many products that are available. One frequently used product is hydroquinone that is used to even skin tone. However, hydroquinone has several shortcomings. The ingredient is controversial for its potential safety issues and it has been banned in Europe. An alternative ingredient that has emerged for its potential use is hexyresorcinol for evening skin tone. Additionally, hexylresorcinol may have other photoaging benefits such as the reduction in the appearance of fine lines. Therefore, the aim of this study is to assess how hexyresorcinol may compare to the use of hydroquinone in the setting of photoaging.

NCT ID: NCT04332796 Completed - Foot Dermatoses Clinical Trials

Chlorhexidine Scrub, ZnO Nanoparticles Socks and the Combination for Treatment of Pitted Keratolysis

PK_treatment
Start date: March 15, 2022
Phase: Phase 4
Study type: Interventional

This study aimed to study the efficacy of chlorhexidine scrub, zinc oxide nanoparticles (ZnO-NPs) socks and the combination of chlorhexidine scrub and ZnO-NPs socks in treatment of pitted keratolysis.

NCT ID: NCT04266405 Completed - Skin Condition Clinical Trials

Efficacy Testing of Collagen and Zhuyin Drinks

Start date: March 9, 2020
Phase: N/A
Study type: Interventional

To assess collagen and zhuyin drink on skin & body condition improvement

NCT ID: NCT04265521 Completed - Skin Diseases Clinical Trials

Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet

Start date: March 3, 2020
Phase: N/A
Study type: Interventional

A prospective, open, post-market study that will enroll male and female subjects diagnosed with foot fungus and at least one of the following conditions: heel cracks, calluses and/or dry feet. The investigation will consist of approximately 48 subjects (considering a 10% drop-out/screening failure rate) fulfilling the eligibility criteria for the study. Each subject will be treated with the study product, BioCool Footcare (footbath), for 3 weeks. The study duration is estimated to 5 months including recruiting, treatment and follow-up period.

NCT ID: NCT04254601 Completed - Skin Diseases Clinical Trials

Laser Therapy Versus Narrow Band Ultraviolet B for the Treatment of Acne Vulgaris

LLLT-NBUB
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Forty-five participants with facial AV were assigned randomly to three groups of fifteen subjects each. Each group received various therapies. Group A (Study group A) had received both NBUB and akne-Mycin; Group B( study group B) had received Red LLLT and akne-Mycin and group C (Control group) received only akne-Mycin cream. All 45 participants are tested at the initial treatments, after 4 weeks and after 8 weeks by the acne count, the intensity scale and the photographic test.

NCT ID: NCT04244539 Completed - Clinical trials for Musculoskeletal Diseases

Efficacy of High-intensity Laser in Jaccoud's Arthropathy in Systemic Lupus Erythematosus

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

A randomized, controlled study with the pretest-posttest design was performed; 50 patients who were suffered from jaccoud's arthropathy and aged 30-50 years. Patients were randomly assigned into two groups: Group 1 (study group): received HILT, in addition to the routine physical therapy program. Group 2 (control group): received routine physical therapy program. All treatment interventions were applied at a frequency of three sessions per week for 8 weeks. The participants were recruited from the air forces hospital at the period from December 2018 and October 2019.

NCT ID: NCT04237818 Completed - Skin Condition Clinical Trials

The Evaluation of Chenopodium Formosanum and Fagopyrum Esculentum Extract on Anti-aging Effect

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

To assess Chenopodium Formosanum and Fagopyrum Esculentum Extract on skin anti-aging

NCT ID: NCT04225091 Completed - Skin Condition Clinical Trials

Efficacy Evaluation of Triple up® Collagen Drink on Skin Condition

Start date: January 30, 2020
Phase: N/A
Study type: Interventional

To assess Triple up® Collagen Drink on skin condition improvement

NCT ID: NCT04144491 Completed - Diarrhea Clinical Trials

Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda

Start date: September 16, 2019
Phase: N/A
Study type: Interventional

This is a nutritional trial with two arms: 1) Intervention arm of Probiotic Yoghurt containing Lactobacillus rhamnosus yoba 2012 and 2) Control arm of custard-like dairy product. The study subjects are 200 children between the age of 3-6 years that attend a school in Southwestern Uganda, Sheema district. Children will be randomized and enrolled in either the yoghurt (100 children) or the placebo (100 children) arm. The children will be monitored for 3 weeks in the baseline in regards to the incidence of common childhood diseases. During these three weeks, stool, saliva and urine samples will be collected. Also measurement of anthropometric indicators (weight and height) will take place. Subsequently, the children will consume either 100ml yoghurt or 100ml placebo product, once per day for five days per week for nine weeks, while being daily monitored in regards to the incidence of common childhood diseases. The same samples (stool, urine and saliva) and assessments (anthropometric) will take place at end line.

NCT ID: NCT04136574 Completed - Hand Dermatoses Clinical Trials

Hand Dermatitis in the Care and Hospital Staff

MANUS-PRO
Start date: July 1, 2019
Phase:
Study type: Observational

Study of the prevalence and risk factors of occupational dermatitis in the hands of caregivers and hospital staff of the Brest CHRU.